Research Oncology


This section is intended for healthcare professionals.


Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. We seek to deliver truly innovative and life-changing treatments for our patients. Underlying our commitment is a proven dedication to changing the course of human health through bold pursuits in science and transformational medicines.

Pathways

Clinical Trials

Pipeline

Immuno-Oncology

Disease Areas

Celgene is committed to improving the lives of patients worldwide. This defines us as a company and is evident in our therapeutic advances across a broad spectrum of diseases. Through our efforts, we continue to make progress in numerous disease areas, building upon the success of a strong foundation in hematologic cancers and in solid tumors.


Acute Myeloid Leukemia

Beta-Thalassemia

Breast Cancer

Lung Cancer

Lymphoma

Myelodysplastic
Syndromes

Multiple Myeloma

Pancreatic Cancer

Scientific Platforms & Pipeline

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients. We take special care to ensure patients’ safe access to our treatments. We have developed unique, industry-leading programs under which hundreds of thousands of patients worldwide have accessed the clinical benefits of our therapies.


Immuno-Oncology

Epigenetics

Protein Homeostasis

Biotherapeutics
and Novel Targets

Celgene Commitment

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. We seek to deliver truly innovative and life-changing treatments for our patients. Underlying our commitment is a proven dedication to changing the course of human health through bold pursuits in science and transformational medicines.


Newsletter

The Celgene Story

Physician
Perspective
Our commitment to medical progress goes hand in hand with our promise to patients: all who can benefit from our discoveries should have the opportunity to do so. At Celgene, patients always come first.